SINGAPORE, Feb. 24, 2023 /PRNewswire/ -- Recently, Beosin, a leading global blockchain security company announced the closing of a new $20 million round of funding. According to the 2022 Web3 Security Annual Report released by Beosin, 48.5% of the 167 attacks that occurred throughout last year were not audited by smart contract security company. After the financing was closed, Beosin made new upgrades to its smart contract security audit service. In terms of the standardization of the audit pr

SHANGHAI, Feb. 27, 2023 /PRNewswire/ -- Recently, China's State Council issued Guidelines for Expanding Domestic Demand (2022-2035), which clearly specifies that China's medical device industry has entered the stage of accelerated demand growth. Meanwhile, the most recent COVID-19 prevention and control optimization policies have made it easier for overseas enterprises to participate in trade fairs held in China for economic and technological exchanges. Under these multiple favorable policies, M

MUMBAI, India, Feb. 24, 2023 /PRNewswire/ -- Tata Communications, a global digital ecosystem enabler, is recognised as a 'Leader' for the tenth consecutive year in the 2023 Gartner® Magic Quadrant™ for Network Services, Global for 'Completeness of Vision' and 'Ability to Execute'. Throughout the year, Tata Communications has enhanced its offering by improving cloud application performance and agility for enterprises to adapt in a rapidly evolving business environment; empowering customers

With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidoplenib (SYK inhibitor) in immune thrombocytopenia (ITP) patients who have failed to respond or relapsed after prior therapy. Cevidoplenib was evaluated in a 61-participant randomized, placebo-controll